Trending
- 1 CNS PHARMACEUTICALS: Announces FDA Approval of IND Application for its Brain Cancer Drug Candidate Berubicin
- 2 V2ACT THERAPEUTICS™: Announces FDA Clearance of an IND Application to proceed with a Phase 1/2a Study of V2ACT for the Treatment of Pancreatic Cancer
Newsletter
Get the latest business news and updates - delivered right to your inbox
By signing up you agree to receive email newsletters or alerts from FDA Health News. You can unsubscribe at any time.